DHI D.R. Horton | $121.29
+3.2% | 4/16/2025 | Target Lowered by | BTIG Research | Analyst Carl Reichardt | Buy -> Buy | $171.00 -> $150.00 | Low | View details for BTIG Research rating of D.R. Horton (NYSE:DHI) on 4/16/2025 |
EOLS Evolus | $10.79
+6.7% | 4/17/2025 | Initiated by | BTIG Research | Analyst Sam Eiber | Buy | $21.00 | Medium | View details for BTIG Research rating of Evolus (NASDAQ:EOLS) on 4/17/2025 |
ISRG Intuitive Surgical | $482.74
+0.3% | 4/14/2025 | Target Set by | BTIG Research | Analyst Ryan Zimmerman | Buy -> Buy | $560.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 4/14/2025 |
SYK Stryker | $346.46
-0.1% | 4/14/2025 | Target Set by | BTIG Research | Analyst Ryan Zimmerman | Buy -> Buy | $403.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 4/14/2025 |
ICAD iCAD | $3.22
+4.9% | 4/16/2025 | Downgraded by | BTIG Research | Analyst M. Thibault | Buy -> Neutral | | Low | View details for BTIG Research rating of iCAD (NASDAQ:ICAD) on 4/16/2025 |
GEHC GE HealthCare Technologies | $62.37
+1.4% | 4/14/2025 | Target Set by | BTIG Research | Analyst Ryan Zimmerman | Buy -> Buy | $95.00 | Low | View details for BTIG Research rating of GE HealthCare Technologies (NASDAQ:GEHC) on 4/14/2025 |
TMHC Taylor Morrison Home | $56.44
+2.8% | 4/16/2025 | Target Set by | BTIG Research | Analyst Carl Reichardt | Buy -> Buy | $75.00 | High | View details for BTIG Research rating of Taylor Morrison Home (NYSE:TMHC) on 4/16/2025 |
ZBH Zimmer Biomet | $97.90
+1.0% | 4/14/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Low | View details for BTIG Research rating of Zimmer Biomet (NYSE:ZBH) on 4/14/2025 |
AMTM Amentum | $18.75
+0.2% | 4/15/2025 | Initiated by | BTIG Research | Analyst Andre Madrid | Buy | $30.00 | Low | View details for BTIG Research rating of Amentum (NYSE:AMTM) on 4/15/2025 |
HUT Hut 8 | C$15.49
+0.8% | 4/14/2025 | Upgraded by | BTIG Research | Analyst G. Lewis | Strong-Buy | | N/A | View details for BTIG Research rating of Hut 8 (TSE:HUT) on 4/14/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
HUT Hut 8 | $11.19
+1.0% | 4/14/2025 | Initiated by | BTIG Research | Analyst Gregory Lewis | Buy | $18.00 | High | View details for BTIG Research rating of Hut 8 (NASDAQ:HUT) on 4/14/2025 |
SRAD Sportradar Group | $23.96
+0.4% | 4/11/2025 | Initiated by | BTIG Research | Analyst Clark Lampen | Buy | $28.00 | Low | View details for BTIG Research rating of Sportradar Group (NASDAQ:SRAD) on 4/11/2025 |
OKLO Oklo | $21.99
+2.0% | 4/11/2025 | Initiated by | BTIG Research | Analyst Gregory Lewis | Neutral | | Low | View details for BTIG Research rating of Oklo (NYSE:OKLO) on 4/11/2025 |
SMR NuScale Power | $14.61
+0.8% | 4/11/2025 | Initiated by | BTIG Research | Analyst Gregory Lewis | Buy | $20.00 | Low | View details for BTIG Research rating of NuScale Power (NYSE:SMR) on 4/11/2025 |
FOUR Shift4 Payments | $76.67
-1.0% | 4/10/2025 | Target Lowered by | BTIG Research | Analyst Hal Goetsch | Buy -> Buy | $135.00 -> $110.00 | Low | View details for BTIG Research rating of Shift4 Payments (NYSE:FOUR) on 4/10/2025 |
ALDX Aldeyra Therapeutics | $2.19
+9.0% | 4/7/2025 | Target Lowered by | BTIG Research | Analyst Thomas Shrader | Buy -> Buy | $11.00 -> $9.00 | High | View details for BTIG Research rating of Aldeyra Therapeutics (NASDAQ:ALDX) on 4/7/2025 |
UPWK Upwork | $12.74
+0.6% | 4/4/2025 | Downgraded by | BTIG Research | Analyst Marvin Fong | Buy -> Neutral | | Medium | View details for BTIG Research rating of Upwork (NASDAQ:UPWK) on 4/4/2025 |
BKNG Booking | $4,573.31
+0.7% | 4/4/2025 | Upgraded by | BTIG Research | Analyst Jake Fuller | Neutral -> Buy | $5,500.00 | High | View details for BTIG Research rating of Booking (NASDAQ:BKNG) on 4/4/2025 |
WING Wingstop | $218.84
+0.5% | 3/25/2025 | Reiterated by | BTIG Research | Analyst P. Saleh | Buy -> Buy | | High | View details for BTIG Research rating of Wingstop (NASDAQ:WING) on 3/25/2025 |
NRXP NRx Pharmaceuticals | $1.93
| 4/2/2025 | Initiated by | BTIG Research | Analyst Thomas Schrader | Buy | $18.00 | High | View details for BTIG Research rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 4/2/2025 |
PGNY Progyny | $21.44
+0.2% | 3/31/2025 | Upgraded by | BTIG Research | Analyst David Larsen | Neutral -> Buy | $28.00 | Medium | View details for BTIG Research rating of Progyny (NASDAQ:PGNY) on 3/31/2025 |
LULU Lululemon Athletica | $251.08
+0.7% | 3/28/2025 | Target Lowered by | BTIG Research | - | Buy | $470.00 -> $420.00 | Medium | View details for BTIG Research rating of Lululemon Athletica (NASDAQ:LULU) on 3/28/2025 |
SGHC Super Group | $7.63
+2.3% | 3/28/2025 | Initiated by | BTIG Research | Analyst Clark Lampen | Buy | $9.00 | Medium | View details for BTIG Research rating of Super Group (NYSE:SGHC) on 3/28/2025 |
ATRC AtriCure | $32.01
-0.2% | 3/27/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | High | View details for BTIG Research rating of AtriCure (NASDAQ:ATRC) on 3/27/2025 |
LNSR LENSAR | $13.91
+1.2% | 3/24/2025 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Strong-Buy -> Hold | | Low | View details for BTIG Research rating of LENSAR (NASDAQ:LNSR) on 3/24/2025 |
LUCD Lucid Diagnostics | $1.21
+11.0% | 3/25/2025 | Target Set by | BTIG Research | - | | $2.00 | Medium | View details for BTIG Research rating of Lucid Diagnostics (NASDAQ:LUCD) on 3/25/2025 |
ALLY Ally Financial | $31.61
-1.8% | 3/25/2025 | Downgraded by | BTIG Research | Analyst V. Caintic | Neutral -> Sell | $30.00 | Medium | View details for BTIG Research rating of Ally Financial (NYSE:ALLY) on 3/25/2025 |
CRWD CrowdStrike | $375.62
-1.1% | 3/25/2025 | Upgraded by | BTIG Research | Analyst Gray Powell | Neutral -> Buy | $431.00 | Medium | View details for BTIG Research rating of CrowdStrike (NASDAQ:CRWD) on 3/25/2025 |
COF Capital One Financial | $162.77
+1.7% | 3/25/2025 | Upgraded by | BTIG Research | Analyst V. Caintic | Neutral -> Buy | $208.00 | Low | View details for BTIG Research rating of Capital One Financial (NYSE:COF) on 3/25/2025 |
OVID Ovid Therapeutics | $0.29
+6.5% | 3/24/2025 | Target Lowered by | BTIG Research | Analyst Thomas Shrader | Buy -> Buy | $5.00 -> $4.00 | Low | View details for BTIG Research rating of Ovid Therapeutics (NASDAQ:OVID) on 3/24/2025 |
OBIO Orchestra BioMed | $2.85
-0.3% | 3/20/2025 | Initiated by | BTIG Research | Analyst Marie Thibault | Buy | $12.00 | High | View details for BTIG Research rating of Orchestra BioMed (NASDAQ:OBIO) on 3/20/2025 |
GBTG Global Business Travel Group | $6.65
+1.4% | 3/18/2025 | Initiated by | BTIG Research | Analyst J. Fuller | Buy | $10.00 | Low | View details for BTIG Research rating of Global Business Travel Group (NYSE:GBTG) on 3/18/2025 |
MXCT MaxCyte | $2.61
+2.4% | 3/12/2025 | Target Set by | BTIG Research | Analyst Mark Massaro | Buy -> Buy | $6.00 | High | View details for BTIG Research rating of MaxCyte (NASDAQ:MXCT) on 3/12/2025 |
EXOD Exodus Movement | $36.58
-1.6% | 3/12/2025 | Initiated by | BTIG Research | Analyst A. Harte | Buy | $40.00 | N/A | View details for BTIG Research rating of Exodus Movement (NYSEAMERICAN:EXOD) on 3/12/2025 |
SOPH SOPHiA GENETICS | $2.83
+0.7% | 3/6/2025 | Target Set by | BTIG Research | - | | $5.00 | High | View details for BTIG Research rating of SOPHiA GENETICS (NASDAQ:SOPH) on 3/6/2025 |
ZS Zscaler | $201.09
-0.9% | 3/6/2025 | Target Set by | BTIG Research | - | Buy -> Buy | $252.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 3/6/2025 |
NTRA Natera | $148.08
-1.4% | 2/28/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Low | View details for BTIG Research rating of Natera (NASDAQ:NTRA) on 2/28/2025 |
OKTA Okta | $97.93
-2.0% | 3/4/2025 | Reiterated by | BTIG Research | - | Buy -> Buy | | Medium | View details for BTIG Research rating of Okta (NASDAQ:OKTA) on 3/4/2025 |
PTGX Protagonist Therapeutics | $46.28
+1.0% | 3/3/2025 | Target Set by | BTIG Research | - | | $73.00 | High | View details for BTIG Research rating of Protagonist Therapeutics (NASDAQ:PTGX) on 3/3/2025 |
ARCT Arcturus Therapeutics | $10.53
+2.2% | 3/10/2025 | Target Set by | BTIG Research | Analyst T. Shrader | Buy -> Buy | $48.00 | Medium | View details for BTIG Research rating of Arcturus Therapeutics (NASDAQ:ARCT) on 3/10/2025 |
[Action Required] Claim Your FREE IRS Loophole Guide (Ad) This shouldn't surprise anyone who's been paying attention, but...
Pres. Trump may be about to unleash the biggest "dollar reset" since 1971. So claim your FREE copy of this 2025 Gold Guide to learn more. |
OPRT Oportun Financial | $4.61
+4.5% | 3/5/2025 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $10.00 | High | View details for BTIG Research rating of Oportun Financial (NASDAQ:OPRT) on 3/5/2025 |
ARDX Ardelyx | $4.82
+4.8% | 3/4/2025 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $14.00 | High | View details for BTIG Research rating of Ardelyx (NASDAQ:ARDX) on 3/4/2025 |
NVAX Novavax | $6.00
-3.2% | 2/28/2025 | Initiated by | BTIG Research | Analyst T. Shrader | Buy | $19.00 | High | View details for BTIG Research rating of Novavax (NASDAQ:NVAX) on 2/28/2025 |
FLYW Flywire | $8.88
+0.6% | 2/26/2025 | Downgraded by | BTIG Research | Analyst A. Harte | Buy -> Neutral | | High | View details for BTIG Research rating of Flywire (NASDAQ:FLYW) on 2/26/2025 |
PYPL PayPal | $61.00
+1.3% | 2/4/2025 | Reiterated by | BTIG Research | - | Neutral -> Neutral | | Low | View details for BTIG Research rating of PayPal (NASDAQ:PYPL) on 2/4/2025 |
CRS Carpenter Technology | $170.19
-1.2% | 1/31/2025 | Target Set by | BTIG Research | Analyst Andre Madrid | | $230.00 | High | View details for BTIG Research rating of Carpenter Technology (NYSE:CRS) on 1/31/2025 |
FLUT Flutter Entertainment | $227.42
+0.1% | 2/3/2025 | Target Set by | BTIG Research | Analyst Clark Lampen | | $323.00 | Low | View details for BTIG Research rating of Flutter Entertainment (NYSE:FLUT) on 2/3/2025 |
DKNG DraftKings | $33.61
0.0% | 2/3/2025 | Target Set by | BTIG Research | Analyst Clark Lampen | | $59.00 | Medium | View details for BTIG Research rating of DraftKings (NASDAQ:DKNG) on 2/3/2025 |
SNOW Snowflake | $143.34
-1.9% | 2/20/2025 | Upgraded by | BTIG Research | Analyst G. Powell | Neutral -> Buy | $220.00 | Medium | View details for BTIG Research rating of Snowflake (NYSE:SNOW) on 2/20/2025 |
GD General Dynamics | $275.70
-0.3% | 2/13/2025 | Downgraded by | BTIG Research | Analyst A. Madrid | Buy -> Neutral | | High | View details for BTIG Research rating of General Dynamics (NYSE:GD) on 2/13/2025 |
STAA STAAR Surgical | $16.89
+4.6% | 2/12/2025 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Buy -> Neutral | | High | View details for BTIG Research rating of STAAR Surgical (NASDAQ:STAA) on 2/12/2025 |
ARR ARMOUR Residential REIT | $14.29
+2.3% | 2/10/2025 | Initiated by | BTIG Research | Analyst E. Hagen | Neutral | | Low | View details for BTIG Research rating of ARMOUR Residential REIT (NYSE:ARR) on 2/10/2025 |
KURA Kura Oncology | $5.90
+2.6% | 2/6/2025 | Downgraded by | BTIG Research | Analyst J. Zelin | Buy -> Neutral | | High | View details for BTIG Research rating of Kura Oncology (NASDAQ:KURA) on 2/6/2025 |
ENVA Enova International | $91.24
+0.2% | 2/5/2025 | Target Raised by | BTIG Research | Analyst V. Caintic | Buy -> Buy | $122.00 -> $129.00 | Low | View details for BTIG Research rating of Enova International (NYSE:ENVA) on 2/5/2025 |
TMCI Treace Medical Concepts | $6.45
-1.2% | 2/4/2025 | Upgraded by | BTIG Research | Analyst R. Zimmerman | Neutral -> Buy | $16.00 | High | View details for BTIG Research rating of Treace Medical Concepts (NASDAQ:TMCI) on 2/4/2025 |
IQV IQVIA | $143.66
-3.2% | 2/3/2025 | Downgraded by | BTIG Research | Analyst D. Larsen | Buy -> Neutral | | Medium | View details for BTIG Research rating of IQVIA (NYSE:IQV) on 2/3/2025 |
MGM MGM Resorts International | $28.89
+1.5% | 2/3/2025 | Downgraded by | BTIG Research | Analyst C. Lampen | Buy -> Neutral | | Medium | View details for BTIG Research rating of MGM Resorts International (NYSE:MGM) on 2/3/2025 |
ARCT Arcturus Therapeutics | $10.53
+2.2% | 1/28/2025 | Initiated by | BTIG Research | Analyst Thomas Shrader | Buy | $41.00 | High | View details for BTIG Research rating of Arcturus Therapeutics (NASDAQ:ARCT) on 1/28/2025 |
AXP American Express | $251.48
-0.6% | 1/24/2025 | Target Raised by | BTIG Research | Analyst V. Caintic | Sell -> Sell | $266.00 -> $270.00 | High | View details for BTIG Research rating of American Express (NYSE:AXP) on 1/24/2025 |
PLD Prologis | $101.89
+1.6% | 1/17/2025 | Target Lowered by | BTIG Research | - | Buy -> Buy | $154.00 -> $134.00 | Medium | View details for BTIG Research rating of Prologis (NYSE:PLD) on 1/17/2025 |
MTCH Match Group | $29.02
+1.3% | 1/14/2025 | Downgraded by | BTIG Research | Analyst J. Fuller | Buy -> Neutral | | Medium | View details for BTIG Research rating of Match Group (NASDAQ:MTCH) on 1/14/2025 |
CART Maplebear | $42.99
+2.2% | 1/14/2025 | Upgraded by | BTIG Research | Analyst J. Fuller | Neutral -> Buy | $58.00 | Medium | View details for BTIG Research rating of Maplebear (NASDAQ:CART) on 1/14/2025 |
BOOT Boot Barn | $91.55
+2.0% | 1/13/2025 | Target Raised by | BTIG Research | Analyst Janine Stichter | Buy -> Buy | $185.00 -> $190.00 | Low | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 1/13/2025 |
IBRX ImmunityBio | $2.47
-0.4% | 1/10/2025 | Initiated by | BTIG Research | Analyst J. Zelin | Buy | $6.00 | High | View details for BTIG Research rating of ImmunityBio (NASDAQ:IBRX) on 1/10/2025 |
NARI Inari Medical | $79.97
| 1/8/2025 | Reiterated by | BTIG Research | Analyst M. Thibault | Buy -> Neutral | | Low | View details for BTIG Research rating of Inari Medical (NASDAQ:NARI) on 1/8/2025 |
PANW Palo Alto Networks | $167.69
-1.2% | 1/8/2025 | Downgraded by | BTIG Research | Analyst G. Powell | Buy -> Neutral | | Medium | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 1/8/2025 |
HIMS Hims & Hers Health | $27.24
+1.1% | 1/7/2025 | Initiated by | BTIG Research | Analyst D. Larsen | Buy | $35.00 | Medium | View details for BTIG Research rating of Hims & Hers Health (NYSE:HIMS) on 1/7/2025 |
VSTM Verastem | $5.74
+15.7% | 12/31/2024 | Target Raised by | BTIG Research | - | Buy | $13.00 -> $20.00 | N/A | View details for BTIG Research rating of Verastem (NASDAQ:VSTM) on 12/31/2024 |
FTAI FTAI Aviation | $93.00
-1.5% | 12/31/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $180.00 -> $190.00 | N/A | View details for BTIG Research rating of FTAI Aviation (NYSE:FTAI) on 12/31/2024 |
SDA SunCar Technology Group | $2.75
+4.2% | 12/30/2024 | Initiated by | BTIG Research | Analyst M. Fong | Buy | $12.00 | N/A | View details for BTIG Research rating of SunCar Technology Group (NASDAQ:SDA) on 12/30/2024 |
IIPR Innovative Industrial Properties | $51.50
+1.1% | 12/23/2024 | Downgraded by | BTIG Research | Analyst T. Catherwood | Buy -> Neutral | | N/A | View details for BTIG Research rating of Innovative Industrial Properties (NYSE:IIPR) on 12/23/2024 |
IREN Iris Energy | $5.61
+2.5% | 12/20/2024 | Initiated by | BTIG Research | Analyst G. Lewis | Buy | $33.00 | N/A | View details for BTIG Research rating of Iris Energy (NASDAQ:IREN) on 12/20/2024 |
LEN Lennar | $104.57
+1.8% | 12/20/2024 | Downgraded by | BTIG Research | Analyst C. Reichardt | Buy -> Neutral | | N/A | View details for BTIG Research rating of Lennar (NYSE:LEN) on 12/20/2024 |
FREY FREYR Battery | $1.05
-1.9% | 12/20/2024 | Upgraded by | BTIG Research | Analyst G. Lewis | Neutral -> Buy | $4.00 | N/A | View details for BTIG Research rating of FREYR Battery (NYSE:FREY) on 12/20/2024 |
AVTX Avalo Therapeutics | $4.41
-4.8% | 12/19/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $40.00 | N/A | View details for BTIG Research rating of Avalo Therapeutics (NASDAQ:AVTX) on 12/19/2024 |
RNAC Cartesian Therapeutics | $10.50
-0.7% | 12/19/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $42.00 | N/A | View details for BTIG Research rating of Cartesian Therapeutics (NASDAQ:RNAC) on 12/19/2024 |
BIRK Birkenstock | $47.60
+0.9% | 12/18/2024 | Target Raised by | BTIG Research | Analyst J. Stichter | Buy | $60.00 -> $70.00 | N/A | View details for BTIG Research rating of Birkenstock (NYSE:BIRK) on 12/18/2024 |
ADPT Adaptive Biotechnologies | $7.33
-2.1% | 12/18/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $8.00 -> $9.00 | N/A | View details for BTIG Research rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 12/18/2024 |
REAX Real Brokerage | $4.67
+1.1% | 12/18/2024 | Initiated by | BTIG Research | Analyst J. Fuller | Buy | $6.00 | N/A | View details for BTIG Research rating of Real Brokerage (NASDAQ:REAX) on 12/18/2024 |
GTLS Chart Industries | $128.61
+3.0% | 12/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $170.00 -> $210.00 | N/A | View details for BTIG Research rating of Chart Industries (NYSE:GTLS) on 12/16/2024 |
BE Bloom Energy | $17.03
-4.5% | 12/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $20.00 -> $30.00 | N/A | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 12/16/2024 |
CORZ Core Scientific | $6.63
+0.6% | 12/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $19.00 -> $20.00 | N/A | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 12/16/2024 |
GAMB Gambling.com Group | $11.97
+0.5% | 12/13/2024 | Target Raised by | BTIG Research | - | Buy | $13.00 -> $19.00 | N/A | View details for BTIG Research rating of Gambling.com Group (NASDAQ:GAMB) on 12/13/2024 |
ELVN Enliven Therapeutics | $16.53
+2.9% | 12/13/2024 | Initiated by | BTIG Research | Analyst J. Zelin | Buy | $42.00 | N/A | View details for BTIG Research rating of Enliven Therapeutics (NASDAQ:ELVN) on 12/13/2024 |
AXDX Accelerate Diagnostics | $0.55
-1.8% | 12/11/2024 | Upgraded by | BTIG Research | Analyst M. Massaro | Strong-Buy | | N/A | View details for BTIG Research rating of Accelerate Diagnostics (NASDAQ:AXDX) on 12/11/2024 |
GMED Globus Medical | $71.03
-0.2% | 12/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $87.00 -> $91.00 | N/A | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 12/12/2024 |
KROS Keros Therapeutics | $14.07
+4.0% | 12/12/2024 | Downgraded by | BTIG Research | Analyst J. Harrison | Buy -> Neutral | | N/A | View details for BTIG Research rating of Keros Therapeutics (NASDAQ:KROS) on 12/12/2024 |
AVDX AvidXchange | $7.60
-1.9% | 12/11/2024 | Initiated by | BTIG Research | Analyst A. Harte | Buy | $14.00 | N/A | View details for BTIG Research rating of AvidXchange (NASDAQ:AVDX) on 12/11/2024 |
NRIX Nurix Therapeutics | $10.24
+4.5% | 12/10/2024 | Initiated by | BTIG Research | Analyst J. Mukherjee | Buy | $35.00 | N/A | View details for BTIG Research rating of Nurix Therapeutics (NASDAQ:NRIX) on 12/10/2024 |
KYMR Kymera Therapeutics | $25.97
+3.8% | 12/10/2024 | Initiated by | BTIG Research | Analyst J. Mukherjee | Buy | $60.00 | N/A | View details for BTIG Research rating of Kymera Therapeutics (NASDAQ:KYMR) on 12/10/2024 |
Real Americans Don’t Wait on Wall Street’s Next Move (Ad) What's happening in the markets right now should concern every freedom-loving American who's worked hard and saved smart.
Your 401(k) doesn't deserve to be dragged through the mud by tariffs, trade wars, reckless spending, and political standoffs.
And you don't have to stand by while Wall Street plays roulette with your future. The Golden Path to Retirement gives you the whole story. |
ARVN Arvinas | $8.60
+12.4% | 12/10/2024 | Initiated by | BTIG Research | Analyst J. Mukherjee | Buy | $69.00 | N/A | View details for BTIG Research rating of Arvinas (NASDAQ:ARVN) on 12/10/2024 |
ONIT Onity Group | $30.02
+2.6% | 12/9/2024 | Upgraded by | BTIG Research | Analyst E. Hagen | Neutral -> Buy | $40.00 | N/A | View details for BTIG Research rating of Onity Group (NYSE:ONIT) on 12/9/2024 |
OKTA Okta | $97.93
-2.0% | 12/4/2024 | Target Raised by | BTIG Research | - | Buy | $98.00 -> $110.00 | N/A | View details for BTIG Research rating of Okta (NASDAQ:OKTA) on 12/4/2024 |
JANX Janux Therapeutics | $29.69
+3.5% | 12/3/2024 | Target Raised by | BTIG Research | - | Buy | $82.00 -> $100.00 | N/A | View details for BTIG Research rating of Janux Therapeutics (NASDAQ:JANX) on 12/3/2024 |
EVH Evolent Health | $8.95
-3.0% | 12/3/2024 | Target Lowered by | BTIG Research | - | Buy | $36.00 -> $29.00 | N/A | View details for BTIG Research rating of Evolent Health (NYSE:EVH) on 12/3/2024 |
BV BrightView | $13.43
+0.3% | 12/2/2024 | Initiated by | BTIG Research | Analyst C. Reichardt | Buy | $22.00 | N/A | View details for BTIG Research rating of BrightView (NYSE:BV) on 12/2/2024 |
ANAB AnaptysBio | $20.55
+7.8% | 12/2/2024 | Downgraded by | BTIG Research | Analyst J. Harrison | Buy -> Neutral | | N/A | View details for BTIG Research rating of AnaptysBio (NASDAQ:ANAB) on 12/2/2024 |
OTLK Outlook Therapeutics | $1.45
+5.8% | 11/29/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $50.00 -> $9.00 | N/A | View details for BTIG Research rating of Outlook Therapeutics (NASDAQ:OTLK) on 11/29/2024 |
REG Regency Centers | $71.66
+2.1% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $72.00 -> $79.00 | N/A | View details for BTIG Research rating of Regency Centers (NASDAQ:REG) on 11/27/2024 |
CDP COPT Defense Properties | $26.36
+0.6% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $33.00 -> $38.00 | N/A | View details for BTIG Research rating of COPT Defense Properties (NYSE:CDP) on 11/27/2024 |
ADC Agree Realty | $78.99
+1.3% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $74.00 -> $78.00 | N/A | View details for BTIG Research rating of Agree Realty (NYSE:ADC) on 11/27/2024 |
ZS Zscaler | $201.09
-0.9% | 11/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $205.00 -> $238.00 | N/A | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 11/27/2024 |
EMBC Embecta | $11.34
| 11/27/2024 | Upgraded by | BTIG Research | Analyst M. Thibault | Neutral -> Buy | $26.00 | N/A | View details for BTIG Research rating of Embecta (NASDAQ:EMBC) on 11/27/2024 |
ALC Alcon | $92.47
+0.5% | 11/26/2024 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Strong-Buy -> Hold | | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 11/26/2024 |
ALEC Alector | $0.92
-5.9% | 11/26/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $16.00 -> $5.00 | N/A | View details for BTIG Research rating of Alector (NASDAQ:ALEC) on 11/26/2024 |
ISRG Intuitive Surgical | $482.74
+0.3% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $535.00 -> $561.00 | N/A | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 11/26/2024 |
GKOS Glaukos | $90.15
+1.5% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $140.00 -> $149.00 | N/A | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 11/26/2024 |
PEN Penumbra | $276.62
-0.4% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $232.00 -> $270.00 | N/A | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 11/26/2024 |
VCEL Vericel | $41.23
+1.0% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $56.00 -> $66.00 | N/A | View details for BTIG Research rating of Vericel (NASDAQ:VCEL) on 11/26/2024 |
EXAS Exact Sciences | $41.58
-1.6% | 11/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $65.00 -> $75.00 | N/A | View details for BTIG Research rating of Exact Sciences (NASDAQ:EXAS) on 11/26/2024 |
VVX V2X | $48.16
-0.6% | 11/25/2024 | Initiated by | BTIG Research | Analyst A. Madrid | Buy | $80.00 | N/A | View details for BTIG Research rating of V2X (NYSE:VVX) on 11/25/2024 |
PANW Palo Alto Networks | $167.69
-1.2% | 11/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $197.50 -> $207.00 | N/A | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 11/21/2024 |
MSTR Strategy | $317.20
+1.8% | 11/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $290.00 -> $570.00 | N/A | View details for BTIG Research rating of Strategy (NASDAQ:MSTR) on 11/21/2024 |
ACRS Aclaris Therapeutics | $1.14
+0.9% | 11/19/2024 | Upgraded by | BTIG Research | Analyst J. Harrison | Neutral -> Buy | $8.00 | N/A | View details for BTIG Research rating of Aclaris Therapeutics (NASDAQ:ACRS) on 11/19/2024 |
VYNE VYNE Therapeutics | $1.85
+2.5% | 11/18/2024 | Initiated by | BTIG Research | Analyst J. Harrison | Buy | $8.00 | N/A | View details for BTIG Research rating of VYNE Therapeutics (NASDAQ:VYNE) on 11/18/2024 |
BE Bloom Energy | $17.03
-4.5% | 11/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $16.00 -> $20.00 | N/A | View details for BTIG Research rating of Bloom Energy (NYSE:BE) on 11/15/2024 |
CIFR Cipher Mining | $2.37
+1.7% | 11/15/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $6.00 -> $9.00 | N/A | View details for BTIG Research rating of Cipher Mining (NASDAQ:CIFR) on 11/15/2024 |
CORZ Core Scientific | $6.63
+0.6% | 11/15/2024 | Target Raised by | BTIG Research | Analyst G. Lewis | Buy -> Buy | $15.00 -> $19.00 | N/A | View details for BTIG Research rating of Core Scientific (NASDAQ:CORZ) on 11/15/2024 |
HQY HealthEquity | $84.52
+2.5% | 11/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $110.00 -> $130.00 | N/A | View details for BTIG Research rating of HealthEquity (NASDAQ:HQY) on 11/14/2024 |
PLUG Plug Power | $0.90
-2.3% | 11/14/2024 | Downgraded by | BTIG Research | Analyst G. Lewis | Buy -> Neutral | | N/A | View details for BTIG Research rating of Plug Power (NASDAQ:PLUG) on 11/14/2024 |
ONON ON | $42.50
+1.8% | 11/13/2024 | Upgraded by | BTIG Research | Analyst J. Stichter | Neutral -> Buy | $64.00 | N/A | View details for BTIG Research rating of ON (NYSE:ONON) on 11/13/2024 |
ATLC Atlanticus | $52.30
+0.7% | 11/12/2024 | Target Raised by | BTIG Research | Analyst V. Caintic | Buy -> Buy | $45.00 -> $54.00 | N/A | View details for BTIG Research rating of Atlanticus (NASDAQ:ATLC) on 11/12/2024 |
VEL Velocity Financial | $17.44
+0.3% | 11/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $20.00 -> $23.00 | N/A | View details for BTIG Research rating of Velocity Financial (NYSE:VEL) on 11/12/2024 |
CCSI Consensus Cloud Solutions | $18.78
+0.2% | 11/11/2024 | Target Raised by | BTIG Research | Analyst D. Larsen | Buy -> Buy | $30.00 -> $32.00 | N/A | View details for BTIG Research rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 11/11/2024 |
FLUT Flutter Entertainment | $227.42
+0.1% | 11/11/2024 | Target Raised by | BTIG Research | Analyst C. Lampen | Buy -> Buy | $249.00 -> $305.00 | N/A | View details for BTIG Research rating of Flutter Entertainment (NYSE:FLUT) on 11/11/2024 |
UPST Upstart | $40.92
+3.8% | 11/11/2024 | Upgraded by | BTIG Research | Analyst V. Caintic | Sell -> Neutral | | N/A | View details for BTIG Research rating of Upstart (NASDAQ:UPST) on 11/11/2024 |
EXPE Expedia Group | $151.15
-0.9% | 11/8/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $175.00 -> $200.00 | N/A | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 11/8/2024 |
PODD Insulet | $246.80
-1.6% | 11/8/2024 | Target Raised by | BTIG Research | Analyst M. Thibault | Buy -> Buy | $260.00 -> $270.00 | N/A | View details for BTIG Research rating of Insulet (NASDAQ:PODD) on 11/8/2024 |
APP AppLovin | $238.22
+3.7% | 11/7/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $202.00 -> $291.00 | N/A | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 11/7/2024 |
UPWK Upwork | $12.74
+0.6% | 11/7/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $14.00 -> $16.00 | N/A | View details for BTIG Research rating of Upwork (NASDAQ:UPWK) on 11/7/2024 |
MELI MercadoLibre | $2,099.37
+1.7% | 11/7/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $2,250.00 -> $2,200.00 | N/A | View details for BTIG Research rating of MercadoLibre (NASDAQ:MELI) on 11/7/2024 |
RVLV Revolve Group | $19.67
+0.0% | 11/6/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $30.00 -> $35.00 | N/A | View details for BTIG Research rating of Revolve Group (NYSE:RVLV) on 11/6/2024 |
EXAS Exact Sciences | $41.58
-1.6% | 11/6/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $82.00 -> $65.00 | N/A | View details for BTIG Research rating of Exact Sciences (NASDAQ:EXAS) on 11/6/2024 |
CDNA CareDx | $17.62
-3.3% | 11/5/2024 | Target Lowered by | BTIG Research | Analyst M. Massaro | Buy -> Buy | $40.00 -> $35.00 | Low | View details for BTIG Research rating of CareDx (NASDAQ:CDNA) on 11/5/2024 |
TCMD Tactile Systems Technology | $13.33
-0.1% | 11/5/2024 | Downgraded by | BTIG Research | Analyst R. Zimmerman | Buy -> Neutral | | High | View details for BTIG Research rating of Tactile Systems Technology (NASDAQ:TCMD) on 11/5/2024 |
FVRR Fiverr International | $24.63
-0.5% | 11/4/2024 | Downgraded by | BTIG Research | Analyst M. Fong | Buy -> Neutral | | Medium | View details for BTIG Research rating of Fiverr International (NYSE:FVRR) on 11/4/2024 |
WRBY Warby Parker | $14.25
-0.1% | 11/1/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $18.00 -> $20.00 | Low | View details for BTIG Research rating of Warby Parker (NYSE:WRBY) on 11/1/2024 |
IQV IQVIA | $143.66
-3.2% | 11/1/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $290.00 -> $260.00 | Low | View details for BTIG Research rating of IQVIA (NYSE:IQV) on 11/1/2024 |
RBLX Roblox | $59.76
+1.1% | 11/1/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $51.00 -> $56.00 | Low | View details for BTIG Research rating of Roblox (NYSE:RBLX) on 11/1/2024 |
WING Wingstop | $218.84
+0.5% | 10/31/2024 | Upgraded by | BTIG Research | Analyst P. Saleh | Neutral -> Buy | $370.00 | Medium | View details for BTIG Research rating of Wingstop (NASDAQ:WING) on 10/31/2024 |
Real Americans Don’t Wait on Wall Street’s Next Move (Ad) What's happening in the markets right now should concern every freedom-loving American who's worked hard and saved smart.
Your 401(k) doesn't deserve to be dragged through the mud by tariffs, trade wars, reckless spending, and political standoffs.
And you don't have to stand by while Wall Street plays roulette with your future. The Golden Path to Retirement gives you the whole story. |
APP AppLovin | $238.22
+3.7% | 10/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $150.00 -> $202.00 | Low | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 10/30/2024 |
SYK Stryker | $346.46
-0.1% | 10/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $383.00 -> $394.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 10/30/2024 |
TTD Trade Desk | $50.26
+3.7% | 10/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $114.00 -> $142.00 | Low | View details for BTIG Research rating of Trade Desk (NASDAQ:TTD) on 10/30/2024 |
DHI D.R. Horton | $121.29
+3.2% | 10/30/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $190.00 -> $186.00 | Low | View details for BTIG Research rating of D.R. Horton (NYSE:DHI) on 10/30/2024 |
AGYS Agilysys | $69.45
+1.2% | 10/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $118.00 -> $124.00 | High | View details for BTIG Research rating of Agilysys (NASDAQ:AGYS) on 10/29/2024 |
BOOT Boot Barn | $91.55
+2.0% | 10/29/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $165.00 -> $185.00 | High | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 10/29/2024 |
NESR National Energy Services Reunited | $6.03
+3.6% | 10/25/2024 | Initiated by | BTIG Research | Analyst G. Lewis | Buy | $15.00 | Medium | View details for BTIG Research rating of National Energy Services Reunited (NASDAQ:NESR) on 10/25/2024 |
TMHC Taylor Morrison Home | $56.44
+2.8% | 10/24/2024 | Target Raised by | BTIG Research | Analyst C. Reichardt | Buy -> Buy | $78.00 -> $86.00 | Low | View details for BTIG Research rating of Taylor Morrison Home (NYSE:TMHC) on 10/24/2024 |
SLP Simulations Plus | $32.69
+1.5% | 10/24/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $60.00 -> $50.00 | High | View details for BTIG Research rating of Simulations Plus (NASDAQ:SLP) on 10/24/2024 |
HLX Helix Energy Solutions Group | $6.83
+4.8% | 10/24/2024 | Downgraded by | BTIG Research | Analyst G. Lewis | Buy -> Neutral | | High | View details for BTIG Research rating of Helix Energy Solutions Group (NYSE:HLX) on 10/24/2024 |
DT Dynatrace | $43.08
-0.3% | 10/23/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $57.00 -> $63.00 | Low | View details for BTIG Research rating of Dynatrace (NYSE:DT) on 10/23/2024 |
ENVA Enova International | $91.24
+0.2% | 10/23/2024 | Target Raised by | BTIG Research | Analyst V. Caintic | Buy -> Buy | $90.00 -> $110.00 | High | View details for BTIG Research rating of Enova International (NYSE:ENVA) on 10/23/2024 |
PHM PulteGroup | $94.87
+2.2% | 10/23/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $139.00 -> $156.00 | Low | View details for BTIG Research rating of PulteGroup (NYSE:PHM) on 10/23/2024 |
CARG CarGurus | $26.61
-0.4% | 10/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $30.00 -> $35.00 | Low | View details for BTIG Research rating of CarGurus (NASDAQ:CARG) on 10/22/2024 |
TRUE TrueCar | $1.28
-2.3% | 10/22/2024 | Target Raised by | BTIG Research | Analyst M. Fong | Buy -> Buy | $3.75 -> $4.50 | Low | View details for BTIG Research rating of TrueCar (NASDAQ:TRUE) on 10/22/2024 |
DECK Deckers Outdoor | $105.66
+2.6% | 10/22/2024 | Downgraded by | BTIG Research | Analyst J. Stichter | Buy -> Neutral | | Low | View details for BTIG Research rating of Deckers Outdoor (NYSE:DECK) on 10/22/2024 |
MSTR Strategy | $317.20
+1.8% | 10/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $180.00 -> $240.00 | Medium | View details for BTIG Research rating of Strategy (NASDAQ:MSTR) on 10/21/2024 |
ISRG Intuitive Surgical | $482.74
+0.3% | 10/18/2024 | Target Set by | BTIG Research | Analyst Ryan Zimmerman | | $535.00 | Medium | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 10/18/2024 |
BIRK Birkenstock | $47.60
+0.9% | 10/18/2024 | Target Set by | BTIG Research | Analyst J. Stichter | Buy -> Buy | $60.00 | Low | View details for BTIG Research rating of Birkenstock (NYSE:BIRK) on 10/18/2024 |
OTLK Outlook Therapeutics | $1.45
+5.8% | 10/18/2024 | Reiterated by | BTIG Research | - | Buy -> Buy | $50.00 -> $50.00 | High | View details for BTIG Research rating of Outlook Therapeutics (NASDAQ:OTLK) on 10/18/2024 |
AURA Aura Biosciences | $5.36
-0.7% | 10/18/2024 | Target Raised by | BTIG Research | Analyst Julian Harrison | Buy -> Buy | $21.00 -> $24.00 | High | View details for BTIG Research rating of Aura Biosciences (NASDAQ:AURA) on 10/18/2024 |
HUMA Humacyte | $1.68
+8.4% | 10/18/2024 | Reiterated by | BTIG Research | Analyst Ryan Zimmerman | Buy -> Buy | $10.00 -> $10.00 | High | View details for BTIG Research rating of Humacyte (NASDAQ:HUMA) on 10/18/2024 |
OKTA Okta | $97.93
-2.0% | 10/17/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $128.00 -> $98.00 | Low | View details for BTIG Research rating of Okta (NASDAQ:OKTA) on 10/17/2024 |
SBUX Starbucks | $81.50
+0.9% | 10/17/2024 | Target Raised by | BTIG Research | Analyst Peter Saleh | Buy -> Buy | $100.00 -> $115.00 | Low | View details for BTIG Research rating of Starbucks (NASDAQ:SBUX) on 10/17/2024 |
INMD InMode | $14.92
+0.1% | 10/17/2024 | Initiated by | BTIG Research | Analyst M. Thibault | Buy | $25.00 | Low | View details for BTIG Research rating of InMode (NASDAQ:INMD) on 10/17/2024 |
APYX Apyx Medical | $0.99
+6.5% | 10/17/2024 | Initiated by | BTIG Research | Analyst M. Thibault | Neutral | | Medium | View details for BTIG Research rating of Apyx Medical (NASDAQ:APYX) on 10/17/2024 |
AIRS AirSculpt Technologies | $1.70
+6.9% | 10/17/2024 | Initiated by | BTIG Research | Analyst M. Thibault | Neutral | | High | View details for BTIG Research rating of AirSculpt Technologies (NASDAQ:AIRS) on 10/17/2024 |
DHT DHT | $10.41
+3.2% | 10/15/2024 | Initiated by | BTIG Research | Analyst G. Lewis | Buy | $16.00 | Medium | View details for BTIG Research rating of DHT (NYSE:DHT) on 10/15/2024 |
ESTA Establishment Labs | $31.45
+4.2% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $62.00 -> $65.00 | Low | View details for BTIG Research rating of Establishment Labs (NASDAQ:ESTA) on 10/14/2024 |
GMED Globus Medical | $71.03
-0.2% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $77.00 -> $78.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 10/14/2024 |
PODD Insulet | $246.80
-1.6% | 10/14/2024 | Target Raised by | BTIG Research | Analyst M. Thibault | Buy -> Buy | $250.00 -> $260.00 | Medium | View details for BTIG Research rating of Insulet (NASDAQ:PODD) on 10/14/2024 |
ISRG Intuitive Surgical | $482.74
+0.3% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $494.00 -> $518.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 10/14/2024 |
MASI Masimo | $152.15
+0.3% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $166.00 -> $170.00 | Low | View details for BTIG Research rating of Masimo (NASDAQ:MASI) on 10/14/2024 |
PEN Penumbra | $276.62
-0.4% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $224.00 -> $234.00 | Low | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 10/14/2024 |
SYK Stryker | $346.46
-0.1% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $374.00 -> $383.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 10/14/2024 |
ALC Alcon | $92.47
+0.5% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $104.00 -> $106.00 | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 10/14/2024 |
BSX Boston Scientific | $95.08
-0.2% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $84.00 -> $93.00 | Low | View details for BTIG Research rating of Boston Scientific (NYSE:BSX) on 10/14/2024 |
CSTL Castle Biosciences | $21.51
+1.2% | 10/14/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $35.00 -> $40.00 | High | View details for BTIG Research rating of Castle Biosciences (NASDAQ:CSTL) on 10/14/2024 |
DPZ Domino's Pizza | $466.74
+1.0% | 10/11/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $580.00 -> $500.00 | Low | View details for BTIG Research rating of Domino’s Pizza (NASDAQ:DPZ) on 10/11/2024 |
FOUR Shift4 Payments | $76.67
-1.0% | 10/10/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $90.00 -> $105.00 | Medium | View details for BTIG Research rating of Shift4 Payments (NYSE:FOUR) on 10/10/2024 |
BIRK Birkenstock | $47.60
+0.9% | 10/10/2024 | Initiated by | BTIG Research | Analyst J. Stichter | Buy | $60.00 | High | View details for BTIG Research rating of Birkenstock (NYSE:BIRK) on 10/10/2024 |
CYBR CyberArk Software | $325.84
-1.6% | 10/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $310.00 -> $325.00 | Low | View details for BTIG Research rating of CyberArk Software (NASDAQ:CYBR) on 10/9/2024 |
BLBD Blue Bird | $33.71
+1.4% | 10/9/2024 | Initiated by | BTIG Research | Analyst G. Lewis | Buy | $55.00 | High | View details for BTIG Research rating of Blue Bird (NASDAQ:BLBD) on 10/9/2024 |
AXP American Express | $251.48
-0.6% | 10/8/2024 | Downgraded by | BTIG Research | Analyst V. Caintic | Neutral -> Sell | $230.00 | Medium | View details for BTIG Research rating of American Express (NYSE:AXP) on 10/8/2024 |
AFRM Affirm | $42.07
+3.2% | 10/8/2024 | Upgraded by | BTIG Research | Analyst V. Caintic | Neutral -> Buy | $68.00 | High | View details for BTIG Research rating of Affirm (NASDAQ:AFRM) on 10/8/2024 |
IART Integra LifeSciences | $15.83
+0.5% | 10/7/2024 | Upgraded by | BTIG Research | Analyst R. Zimmerman | Sell -> Neutral | | High | View details for BTIG Research rating of Integra LifeSciences (NASDAQ:IART) on 10/7/2024 |
FRO Frontline | $15.43
+4.4% | 10/7/2024 | Upgraded by | BTIG Research | Analyst G. Lewis | Neutral -> Buy | $30.00 | High | View details for BTIG Research rating of Frontline (NYSE:FRO) on 10/7/2024 |
ZBH Zimmer Biomet | $97.90
+1.0% | 10/3/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $134.00 -> $126.00 | Low | View details for BTIG Research rating of Zimmer Biomet (NYSE:ZBH) on 10/3/2024 |
ASTH Astrana Health | $31.38
-4.0% | 10/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $60.00 -> $70.00 | Medium | View details for BTIG Research rating of Astrana Health (NASDAQ:ASTH) on 10/3/2024 |
BTSG BrightSpring Health Services | $16.60
-1.2% | 10/3/2024 | Target Raised by | BTIG Research | Analyst D. Larsen | Buy -> Buy | $15.00 -> $20.00 | Low | View details for BTIG Research rating of BrightSpring Health Services (NASDAQ:BTSG) on 10/3/2024 |
[Action Required] Claim Your FREE IRS Loophole Guide (Ad) This shouldn't surprise anyone who's been paying attention, but...
Pres. Trump may be about to unleash the biggest "dollar reset" since 1971. So claim your FREE copy of this 2025 Gold Guide to learn more. |
ADPT Adaptive Biotechnologies | $7.33
-2.1% | 10/2/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $7.00 -> $8.00 | Low | View details for BTIG Research rating of Adaptive Biotechnologies (NASDAQ:ADPT) on 10/2/2024 |
NKTR Nektar Therapeutics | $0.64
+4.9% | 9/30/2024 | Reiterated by | BTIG Research | Analyst J. Harrison | Buy | $4.00 | High | View details for BTIG Research rating of Nektar Therapeutics (NASDAQ:NKTR) on 9/30/2024 |
EXPE Expedia Group | $151.15
-0.9% | 9/27/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $150.00 -> $175.00 | Low | View details for BTIG Research rating of Expedia Group (NASDAQ:EXPE) on 9/27/2024 |
VRDN Viridian Therapeutics | $13.13
+3.8% | 9/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $56.00 -> $61.00 | Low | View details for BTIG Research rating of Viridian Therapeutics (NASDAQ:VRDN) on 9/26/2024 |
LSPD Lightspeed Commerce | $9.30
+1.5% | 9/26/2024 | Reiterated by | BTIG Research | - | Buy -> Buy | $21.00 -> $21.00 | High | View details for BTIG Research rating of Lightspeed Commerce (NYSE:LSPD) on 9/26/2024 |
GPN Global Payments | $69.50
-17.4% | 9/25/2024 | Downgraded by | BTIG Research | Analyst A. Harte | Buy -> Neutral | | High | View details for BTIG Research rating of Global Payments (NYSE:GPN) on 9/25/2024 |
DRI Darden Restaurants | $200.03
+1.1% | 9/20/2024 | Target Raised by | BTIG Research | Analyst P. Saleh | Buy -> Buy | $175.00 -> $195.00 | Low | View details for BTIG Research rating of Darden Restaurants (NYSE:DRI) on 9/20/2024 |
DASH DoorDash | $181.24
+1.0% | 9/19/2024 | Upgraded by | BTIG Research | Analyst J. Fuller | Neutral -> Buy | $155.00 | Low | View details for BTIG Research rating of DoorDash (NASDAQ:DASH) on 9/19/2024 |
GEHC GE HealthCare Technologies | $62.37
+1.4% | 9/18/2024 | Upgraded by | BTIG Research | Analyst R. Zimmerman | Neutral -> Buy | $100.00 | Low | View details for BTIG Research rating of GE HealthCare Technologies (NASDAQ:GEHC) on 9/18/2024 |
AVAV AeroVironment | $147.61
+2.6% | 9/17/2024 | Reiterated by | BTIG Research | Analyst A. Madrid | Buy -> Buy | $245.00 -> $245.00 | Low | View details for BTIG Research rating of AeroVironment (NASDAQ:AVAV) on 9/17/2024 |
DH Definitive Healthcare | $2.53
| 9/17/2024 | Initiated by | BTIG Research | Analyst D. Larsen | Buy | $7.00 | High | View details for BTIG Research rating of Definitive Healthcare (NASDAQ:DH) on 9/17/2024 |
SYF Synchrony Financial | $47.86
+2.4% | 9/16/2024 | Downgraded by | BTIG Research | Analyst V. Caintic | Buy -> Neutral | | Low | View details for BTIG Research rating of Synchrony Financial (NYSE:SYF) on 9/16/2024 |
ALLY Ally Financial | $31.61
-1.8% | 9/16/2024 | Downgraded by | BTIG Research | Analyst V. Caintic | Buy -> Neutral | | Low | View details for BTIG Research rating of Ally Financial (NYSE:ALLY) on 9/16/2024 |
APP AppLovin | $238.22
+3.7% | 9/13/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $114.00 -> $150.00 | High | View details for BTIG Research rating of AppLovin (NASDAQ:APP) on 9/13/2024 |
NFE New Fortress Energy | $5.69
+2.7% | 9/13/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $35.00 -> $15.00 | High | View details for BTIG Research rating of New Fortress Energy (NASDAQ:NFE) on 9/13/2024 |
ALC Alcon | $92.47
+0.5% | 9/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $98.00 -> $104.00 | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 9/12/2024 |
RZLT Rezolute | $2.75
+4.2% | 9/10/2024 | Target Raised by | BTIG Research | Analyst J. Harrison | Buy -> Buy | $13.00 -> $15.00 | Low | View details for BTIG Research rating of Rezolute (NASDAQ:RZLT) on 9/10/2024 |
VRDN Viridian Therapeutics | $13.13
+3.8% | 9/10/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $46.00 -> $56.00 | High | View details for BTIG Research rating of Viridian Therapeutics (NASDAQ:VRDN) on 9/10/2024 |
BOOT Boot Barn | $91.55
+2.0% | 9/10/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $150.00 -> $165.00 | High | View details for BTIG Research rating of Boot Barn (NYSE:BOOT) on 9/10/2024 |
HAE Haemonetics | $57.10
+0.4% | 9/10/2024 | Initiated by | BTIG Research | Analyst M. Thibault | Buy | $112.00 | Medium | View details for BTIG Research rating of Haemonetics (NYSE:HAE) on 9/10/2024 |
BNGO Bionano Genomics | $4.05
| 9/10/2024 | Downgraded by | BTIG Research | Analyst M. Massaro | Buy -> Neutral | | High | View details for BTIG Research rating of Bionano Genomics (NASDAQ:BNGO) on 9/10/2024 |
RBLX Roblox | $59.76
+1.1% | 9/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $47.00 -> $51.00 | High | View details for BTIG Research rating of Roblox (NYSE:RBLX) on 9/9/2024 |
SOLV Solventum | $66.23
+0.8% | 9/5/2024 | Initiated by | BTIG Research | Analyst R. Zimmerman | Neutral | | Low | View details for BTIG Research rating of Solventum (NYSE:SOLV) on 9/5/2024 |
GTLB GitLab | $42.90
+1.7% | 9/4/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $58.00 -> $63.00 | Low | View details for BTIG Research rating of GitLab (NASDAQ:GTLB) on 9/4/2024 |
ZS Zscaler | $201.09
-0.9% | 9/4/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $220.00 -> $205.00 | Low | View details for BTIG Research rating of Zscaler (NASDAQ:ZS) on 9/4/2024 |
PCVX Vaxcyte | $30.65
+5.3% | 9/3/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $98.00 -> $160.00 | Low | View details for BTIG Research rating of Vaxcyte (NASDAQ:PCVX) on 9/3/2024 |
GWRE Guidewire Software | $191.18
-0.5% | 8/30/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $140.00 -> $165.00 | Low | View details for BTIG Research rating of Guidewire Software (NYSE:GWRE) on 8/30/2024 |
SYK Stryker | $346.46
-0.1% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $360.00 -> $374.00 | Low | View details for BTIG Research rating of Stryker (NYSE:SYK) on 8/28/2024 |
PEN Penumbra | $276.62
-0.4% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $187.00 -> $224.00 | Low | View details for BTIG Research rating of Penumbra (NYSE:PEN) on 8/28/2024 |
ISRG Intuitive Surgical | $482.74
+0.3% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $469.00 -> $494.00 | Low | View details for BTIG Research rating of Intuitive Surgical (NASDAQ:ISRG) on 8/28/2024 |
IART Integra LifeSciences | $15.83
+0.5% | 8/28/2024 | Target Lowered by | BTIG Research | Analyst R. Zimmerman | Sell -> Sell | $22.00 -> $20.00 | Low | View details for BTIG Research rating of Integra LifeSciences (NASDAQ:IART) on 8/28/2024 |
GMED Globus Medical | $71.03
-0.2% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $75.00 -> $77.00 | Low | View details for BTIG Research rating of Globus Medical (NYSE:GMED) on 8/28/2024 |
GKOS Glaukos | $90.15
+1.5% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $131.00 -> $139.00 | Low | View details for BTIG Research rating of Glaukos (NYSE:GKOS) on 8/28/2024 |
S SentinelOne | $16.82
-1.6% | 8/28/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $28.00 -> $30.00 | Low | View details for BTIG Research rating of SentinelOne (NYSE:S) on 8/28/2024 |
FI Fiserv | $208.51
-0.8% | 8/28/2024 | Initiated by | BTIG Research | Analyst A. Harte | Buy | $200.00 | Low | View details for BTIG Research rating of Fiserv (NYSE:FI) on 8/28/2024 |
QTWO Q2 | $74.97
+0.1% | 8/26/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $75.00 -> $82.00 | Low | View details for BTIG Research rating of Q2 (NYSE:QTWO) on 8/26/2024 |
FTAI FTAI Aviation | $93.00
-1.5% | 8/26/2024 | Initiated by | BTIG Research | - | Buy | $80.00 -> $140.00 | Low | View details for BTIG Research rating of FTAI Aviation (NYSE:FTAI) on 8/26/2024 |
DNA Ginkgo Bioworks | $7.84
-3.2% | 8/23/2024 | Target Raised by | BTIG Research | Analyst M. Massaro | Sell -> Sell | $0.20 -> $7.00 | Low | View details for BTIG Research rating of Ginkgo Bioworks (NYSE:DNA) on 8/23/2024 |
ALC Alcon | $92.47
+0.5% | 8/22/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $96.00 -> $98.00 | N/A | View details for BTIG Research rating of Alcon (NYSE:ALC) on 8/22/2024 |
MELI MercadoLibre | $2,099.37
+1.7% | 8/21/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $2,025.00 -> $2,250.00 | Low | View details for BTIG Research rating of MercadoLibre (NASDAQ:MELI) on 8/21/2024 |
CCSI Consensus Cloud Solutions | $18.78
+0.2% | 8/21/2024 | Upgraded by | BTIG Research | Analyst D. Larsen | Neutral -> Buy | $30.00 | Low | View details for BTIG Research rating of Consensus Cloud Solutions (NASDAQ:CCSI) on 8/21/2024 |
PANW Palo Alto Networks | $167.69
-1.2% | 8/20/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $183.00 -> $197.50 | Low | View details for BTIG Research rating of Palo Alto Networks (NASDAQ:PANW) on 8/20/2024 |
LQDA Liquidia | $13.72
+0.3% | 8/19/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $29.00 -> $25.00 | Low | View details for BTIG Research rating of Liquidia (NASDAQ:LQDA) on 8/19/2024 |
CDNA CareDx | $17.62
-3.3% | 8/19/2024 | Upgraded by | BTIG Research | Analyst M. Massaro | Neutral -> Buy | $40.00 | Low | View details for BTIG Research rating of CareDx (NASDAQ:CDNA) on 8/19/2024 |
OS Onestream | $19.66
+1.3% | 8/19/2024 | Initiated by | BTIG Research | Analyst M. Vanvliet | Buy | $37.00 | Low | View details for BTIG Research rating of Onestream (NASDAQ:OS) on 8/19/2024 |
TMHC Taylor Morrison Home | $56.44
+2.8% | 8/19/2024 | Upgraded by | BTIG Research | Analyst C. Reichardt | Neutral -> Buy | $78.00 | Low | View details for BTIG Research rating of Taylor Morrison Home (NYSE:TMHC) on 8/19/2024 |
PSNL Personalis | $3.19
-3.0% | 8/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $5.50 -> $7.00 | Low | View details for BTIG Research rating of Personalis (NASDAQ:PSNL) on 8/16/2024 |
RVLV Revolve Group | $19.67
+0.0% | 8/16/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $24.00 -> $26.00 | Low | View details for BTIG Research rating of Revolve Group (NYSE:RVLV) on 8/16/2024 |
PYCR Paycor HCM | $22.49
| 8/15/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $26.00 -> $20.00 | Low | View details for BTIG Research rating of Paycor HCM (NASDAQ:PYCR) on 8/15/2024 |
FLUT Flutter Entertainment | $227.42
+0.1% | 8/14/2024 | Target Raised by | BTIG Research | Analyst C. Lampen | Buy -> Buy | $245.00 -> $249.00 | Low | View details for BTIG Research rating of Flutter Entertainment (NYSE:FLUT) on 8/14/2024 |
ENVA Enova International | $91.24
+0.2% | 8/14/2024 | Initiated by | BTIG Research | Analyst V. Caintic | Buy | $90.00 | Low | View details for BTIG Research rating of Enova International (NYSE:ENVA) on 8/14/2024 |
ZTS Zoetis | $148.64
+1.3% | 8/12/2024 | Target Raised by | BTIG Research | Analyst M. Massaro | Buy -> Buy | $220.00 -> $225.00 | Low | View details for BTIG Research rating of Zoetis (NYSE:ZTS) on 8/12/2024 |
IRT Independence Realty Trust | $19.09
+1.2% | 8/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $18.00 -> $21.00 | Low | View details for BTIG Research rating of Independence Realty Trust (NYSE:IRT) on 8/12/2024 |
CSR Centerspace | $57.60
+0.1% | 8/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $69.00 -> $79.00 | Low | View details for BTIG Research rating of Centerspace (NYSE:CSR) on 8/12/2024 |
ADC Agree Realty | $78.99
+1.3% | 8/12/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $65.00 -> $74.00 | Low | View details for BTIG Research rating of Agree Realty (NYSE:ADC) on 8/12/2024 |
TTD Trade Desk | $50.26
+3.7% | 8/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $110.00 -> $114.00 | Low | View details for BTIG Research rating of Trade Desk (NASDAQ:TTD) on 8/9/2024 |
FIVN Five9 | $22.32
-1.3% | 8/9/2024 | Target Lowered by | BTIG Research | - | Buy -> Buy | $100.00 -> $45.00 | Low | View details for BTIG Research rating of Five9 (NASDAQ:FIVN) on 8/9/2024 |
PODD Insulet | $246.80
-1.6% | 8/9/2024 | Target Lowered by | BTIG Research | Analyst M. Thibault | Buy -> Buy | $270.00 -> $250.00 | Low | View details for BTIG Research rating of Insulet (NASDAQ:PODD) on 8/9/2024 |
CARG CarGurus | $26.61
-0.4% | 8/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $28.00 -> $30.00 | Low | View details for BTIG Research rating of CarGurus (NASDAQ:CARG) on 8/9/2024 |
NTRA Natera | $148.08
-1.4% | 8/9/2024 | Target Raised by | BTIG Research | - | Buy -> Buy | $125.00 -> $135.00 | Low | View details for BTIG Research rating of Natera (NASDAQ:NTRA) on 8/9/2024 |
